Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study

Abstract Although frequent chronic obstructive pulmonary disease (COPD) exacerbation has been associated with the isolation of Pseudomonas aeruginosa (PA) in sputum cultures, it remains unknown whether the empirical use of anti-pseudomonal antibiotics can improve outcomes in patients with frequent C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Akihiro Shiroshita, Chisato Miyakoshi, Shunta Tsutsumi, Hiroshi Shiba, Chigusa Shirakawa, Kenya Sato, Shinya Matsushita, Yuya Kimura, Keisuke Tomii, Masahiro Ohgiya, Yuki Kataoka
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/72333421deff41d9953a3a71f019955f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:72333421deff41d9953a3a71f019955f
record_format dspace
spelling oai:doaj.org-article:72333421deff41d9953a3a71f019955f2021-12-02T18:37:08ZEffectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study10.1038/s41598-021-99640-y2045-2322https://doaj.org/article/72333421deff41d9953a3a71f019955f2021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99640-yhttps://doaj.org/toc/2045-2322Abstract Although frequent chronic obstructive pulmonary disease (COPD) exacerbation has been associated with the isolation of Pseudomonas aeruginosa (PA) in sputum cultures, it remains unknown whether the empirical use of anti-pseudomonal antibiotics can improve outcomes in patients with frequent COPD exacerbations. This multicenter retrospective cohort study evaluated whether the empirical use of anti-pseudomonal antibiotics improves the length of the hospital stay in patients with recurrent COPD exacerbation (≥ 2 admissions from April 1, 2008 to July 31, 2020). For statistical analysis, a log-linked Gamma model was used. Parameters were estimated using a generalized estimating equation model with an exchangeable correlation structure accounting for repeated observations from a single patient. Covariates included age, body mass index, home oxygen therapy use, respiratory rate, heart rate, oxygen use on admission, mental status, systemic steroid use, activities of daily living, and the number of recurrences. Hospital-specific effects were specified as fixed effects. In total, 344 patients and 965 observations of recurrent COPD exacerbations were selected. Anti-pseudomonal antibiotics were used in 173 patients (18%). The estimated change in the length of the hospital stay between anti-pseudomonal and non-anti-pseudomonal antibiotics groups was 0.039 days [95% confidence interval; − 0.083, 0.162]. Anti-pseudomonal antibiotics could not shorten the length of the hospital stay.Akihiro ShiroshitaChisato MiyakoshiShunta TsutsumiHiroshi ShibaChigusa ShirakawaKenya SatoShinya MatsushitaYuya KimuraKeisuke TomiiMasahiro OhgiyaYuki KataokaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Akihiro Shiroshita
Chisato Miyakoshi
Shunta Tsutsumi
Hiroshi Shiba
Chigusa Shirakawa
Kenya Sato
Shinya Matsushita
Yuya Kimura
Keisuke Tomii
Masahiro Ohgiya
Yuki Kataoka
Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
description Abstract Although frequent chronic obstructive pulmonary disease (COPD) exacerbation has been associated with the isolation of Pseudomonas aeruginosa (PA) in sputum cultures, it remains unknown whether the empirical use of anti-pseudomonal antibiotics can improve outcomes in patients with frequent COPD exacerbations. This multicenter retrospective cohort study evaluated whether the empirical use of anti-pseudomonal antibiotics improves the length of the hospital stay in patients with recurrent COPD exacerbation (≥ 2 admissions from April 1, 2008 to July 31, 2020). For statistical analysis, a log-linked Gamma model was used. Parameters were estimated using a generalized estimating equation model with an exchangeable correlation structure accounting for repeated observations from a single patient. Covariates included age, body mass index, home oxygen therapy use, respiratory rate, heart rate, oxygen use on admission, mental status, systemic steroid use, activities of daily living, and the number of recurrences. Hospital-specific effects were specified as fixed effects. In total, 344 patients and 965 observations of recurrent COPD exacerbations were selected. Anti-pseudomonal antibiotics were used in 173 patients (18%). The estimated change in the length of the hospital stay between anti-pseudomonal and non-anti-pseudomonal antibiotics groups was 0.039 days [95% confidence interval; − 0.083, 0.162]. Anti-pseudomonal antibiotics could not shorten the length of the hospital stay.
format article
author Akihiro Shiroshita
Chisato Miyakoshi
Shunta Tsutsumi
Hiroshi Shiba
Chigusa Shirakawa
Kenya Sato
Shinya Matsushita
Yuya Kimura
Keisuke Tomii
Masahiro Ohgiya
Yuki Kataoka
author_facet Akihiro Shiroshita
Chisato Miyakoshi
Shunta Tsutsumi
Hiroshi Shiba
Chigusa Shirakawa
Kenya Sato
Shinya Matsushita
Yuya Kimura
Keisuke Tomii
Masahiro Ohgiya
Yuki Kataoka
author_sort Akihiro Shiroshita
title Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
title_short Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
title_full Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
title_fullStr Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
title_full_unstemmed Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
title_sort effectiveness of empirical anti-pseudomonal antibiotics for recurrent copd exacerbation: a multicenter retrospective cohort study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/72333421deff41d9953a3a71f019955f
work_keys_str_mv AT akihiroshiroshita effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT chisatomiyakoshi effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT shuntatsutsumi effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT hiroshishiba effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT chigusashirakawa effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT kenyasato effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT shinyamatsushita effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT yuyakimura effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT keisuketomii effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT masahiroohgiya effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
AT yukikataoka effectivenessofempiricalantipseudomonalantibioticsforrecurrentcopdexacerbationamulticenterretrospectivecohortstudy
_version_ 1718377804981075968